期刊文献+

血红素加氧酶-1与糖尿病周围神经病变的研究进展 被引量:7

The progression on the research of haem oxygenase-1 and diabetic peripheral neuropathy
原文传递
导出
摘要 DPN的发生发展是复杂的、多种致病因素共同作用的结果,氧化应激(OS)和炎症在其中发挥重要作用。血红素加氧酶-1(HO-1)及其降解产物具有抗氧化、抗炎、抗凋亡、促血管生成等多种功效,可作为DPN防治研究的新靶点。 The pathogenesis of diabetic peripheral neuropathy(DPN)is the result of complex multiple concurrent pathogenic factors,among which oxidative stress and inflammation play important roles.Multiple data have indicated that haem oxygenase-1(HO-1)and its degradation products products possess the functions of anti-oxidation,anti-inflammation,anti-apoptosis and pro-angiogenesis,which now becomes a new target for the treatment of DPN.We will briefly review the progression on the research of HO-1and DPN.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第7期653-656,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金(81001580)
关键词 糖尿病周围神经病变 氧化应激 炎症 血红素加氧酶-1 Diabetic peripheral neuropathy(DPN) Oxidative stress(OS) Inflammation Haem oxygenase-1(HO-1)
  • 相关文献

参考文献21

  • 1Shaw JE,Sicree RA,Zimmet PZ. Global estimates of the preva- lence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010,87:4-14.
  • 2Farmer KL,Li C,Dobrowsky RT. Diabetic peripheral neuropa- thy:should a chaperone accompany our therapeutic approach? Pharmacol Rev, 2012,64 : 880-900.
  • 3Kim H, Kim JJ, Yoon 5(8. Emerging therapy for diabetic neu ropathy: cell therapy targeting vessels and nerves. Endocr Metab Immune Disord Drug Targets, 2012,12 : 168-178.
  • 4Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protec- tion by berne oxygenase-1. Annu Rev Pharmaeol Toxicol, 2010,50:323 354.
  • 5Grochot-Przeczek, Dulak J, Jozkowiez A. Haem oxygenasc-l: non-canonical roles in physiology and pathology. Clin Sci (Lond), 2012,122 : 93-103.
  • 6Barbagallo I,Marrazzo G,Frigiola A,et al. Role of carbon mon- oxide in vascular diseases. Curr Pharm Biotechnol, 2012, 13: 787-796.
  • 7Leffler CW, Parfenova H,Jaggar JH. Carbon monoxide as an endogenous vascular modulator. Am J physiol Heart Circ Phys- iol, 2011,301 : HI-H11.
  • 8Maines MD. Potential application of biliverdinreductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings. Curr Drug Targets,2010,11: 1586-1594.
  • 9Pae HO,Chung HT. Heme oxygenase 1 :its therapeutic roles in inflammatory diseases. Immune Netw, 2009,9 : 9-12.
  • 10Grochot-Przeczek A,Dulak J, Jozkowicz A. Heme oxygenase-1 in neovascularisation= A diabetic perspective. Thromb Haem ost, 2010,104 : 424-431.

同被引文献61

引证文献7

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部